

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.05515354 |
| 2 | maintenance of protein location in nucleus (GO:0051457) | 6.55203646 |
| 3 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 6.43948504 |
| 4 | protein localization to kinetochore (GO:0034501) | 6.40624336 |
| 5 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 6.31120300 |
| 6 | nodal signaling pathway (GO:0038092) | 6.17815557 |
| 7 | regulation of telomere maintenance via telomerase (GO:0032210) | 6.03251675 |
| 8 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 6.00483147 |
| 9 | negative regulation of telomerase activity (GO:0051974) | 5.84110556 |
| 10 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 5.75641693 |
| 11 | histone H4-K12 acetylation (GO:0043983) | 5.72780792 |
| 12 | regulation of response to osmotic stress (GO:0047484) | 5.63097063 |
| 13 | histone H4-K8 acetylation (GO:0043982) | 5.58267800 |
| 14 | histone H4-K5 acetylation (GO:0043981) | 5.58267800 |
| 15 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.48651377 |
| 16 | rRNA transcription (GO:0009303) | 5.43915873 |
| 17 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.43479600 |
| 18 | muscle organ morphogenesis (GO:0048644) | 5.23466146 |
| 19 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.20411195 |
| 20 | mitotic sister chromatid segregation (GO:0000070) | 5.12342042 |
| 21 | rRNA methylation (GO:0031167) | 5.01027730 |
| 22 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 4.95310830 |
| 23 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.88343958 |
| 24 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.88343958 |
| 25 | cell migration involved in gastrulation (GO:0042074) | 4.86831879 |
| 26 | rRNA modification (GO:0000154) | 4.82436029 |
| 27 | chromatin remodeling at centromere (GO:0031055) | 4.77751762 |
| 28 | protein localization to chromosome, centromeric region (GO:0071459) | 4.76866183 |
| 29 | regulation of mesoderm development (GO:2000380) | 4.75629529 |
| 30 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.70348640 |
| 31 | CENP-A containing nucleosome assembly (GO:0034080) | 4.69707521 |
| 32 | heterochromatin organization (GO:0070828) | 4.66434785 |
| 33 | DNA replication checkpoint (GO:0000076) | 4.61698301 |
| 34 | negative regulation of telomere maintenance (GO:0032205) | 4.53868394 |
| 35 | regulation of translation in response to stress (GO:0043555) | 4.51686131 |
| 36 | nuclear pore complex assembly (GO:0051292) | 4.51400315 |
| 37 | regulation of cilium movement (GO:0003352) | 4.50513993 |
| 38 | proteasome assembly (GO:0043248) | 4.45489064 |
| 39 | cytidine metabolic process (GO:0046087) | 4.34678266 |
| 40 | cytidine catabolic process (GO:0006216) | 4.34678266 |
| 41 | cytidine deamination (GO:0009972) | 4.34678266 |
| 42 | nucleoside transmembrane transport (GO:1901642) | 4.28830599 |
| 43 | chaperone-mediated protein transport (GO:0072321) | 4.24150010 |
| 44 | chromatin assembly (GO:0031497) | 4.23152898 |
| 45 | sister chromatid segregation (GO:0000819) | 4.22718233 |
| 46 | female gonad development (GO:0008585) | 4.22007907 |
| 47 | regulation of SMAD protein import into nucleus (GO:0060390) | 4.21008602 |
| 48 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.17433213 |
| 49 | quinone metabolic process (GO:1901661) | 4.15012762 |
| 50 | phenol-containing compound catabolic process (GO:0019336) | 4.12999144 |
| 51 | establishment of integrated proviral latency (GO:0075713) | 4.11518117 |
| 52 | nuclear pore organization (GO:0006999) | 4.09010374 |
| 53 | histone H4-K16 acetylation (GO:0043984) | 4.08093350 |
| 54 | hormone catabolic process (GO:0042447) | 4.05814157 |
| 55 | interferon-gamma production (GO:0032609) | 4.02420646 |
| 56 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.99493320 |
| 57 | lung-associated mesenchyme development (GO:0060484) | 3.95719648 |
| 58 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.95104123 |
| 59 | histone exchange (GO:0043486) | 3.93695957 |
| 60 | cullin deneddylation (GO:0010388) | 3.91061639 |
| 61 | ribosome biogenesis (GO:0042254) | 3.90147097 |
| 62 | mitotic metaphase plate congression (GO:0007080) | 3.80764185 |
| 63 | lung morphogenesis (GO:0060425) | 3.80540044 |
| 64 | DNA replication-independent nucleosome organization (GO:0034724) | 3.77309681 |
| 65 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.77309681 |
| 66 | protein complex localization (GO:0031503) | 3.77022479 |
| 67 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.76068398 |
| 68 | regulation of gene silencing by miRNA (GO:0060964) | 3.76068398 |
| 69 | regulation of gene silencing by RNA (GO:0060966) | 3.76068398 |
| 70 | regulation of timing of cell differentiation (GO:0048505) | 3.75044805 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.74967200 |
| 72 | embryonic process involved in female pregnancy (GO:0060136) | 3.73703562 |
| 73 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.70361502 |
| 74 | anterior/posterior axis specification, embryo (GO:0008595) | 3.70332877 |
| 75 | formation of translation preinitiation complex (GO:0001731) | 3.68349133 |
| 76 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.66911927 |
| 77 | regulation of telomerase activity (GO:0051972) | 3.63831826 |
| 78 | regulation of telomere maintenance (GO:0032204) | 3.62770449 |
| 79 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.62039510 |
| 80 | pre-miRNA processing (GO:0031054) | 3.58856286 |
| 81 | pseudouridine synthesis (GO:0001522) | 3.58401487 |
| 82 | transcription from mitochondrial promoter (GO:0006390) | 3.57250508 |
| 83 | maintenance of protein localization in organelle (GO:0072595) | 3.57034776 |
| 84 | regulation of activin receptor signaling pathway (GO:0032925) | 3.56958706 |
| 85 | regulation of development, heterochronic (GO:0040034) | 3.56251048 |
| 86 | intestinal epithelial cell development (GO:0060576) | 3.54862444 |
| 87 | GDP-mannose metabolic process (GO:0019673) | 3.52923927 |
| 88 | regulation of stem cell maintenance (GO:2000036) | 3.52398333 |
| 89 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.52048919 |
| 90 | protein deneddylation (GO:0000338) | 3.45196491 |
| 91 | DNA damage response, detection of DNA damage (GO:0042769) | 3.44360210 |
| 92 | DNA duplex unwinding (GO:0032508) | 3.44015525 |
| 93 | digestive tract morphogenesis (GO:0048546) | 3.41476265 |
| 94 | pore complex assembly (GO:0046931) | 3.40481406 |
| 95 | DNA geometric change (GO:0032392) | 3.40186276 |
| 96 | negative regulation of ligase activity (GO:0051352) | 3.39925110 |
| 97 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.39925110 |
| 98 | IMP biosynthetic process (GO:0006188) | 3.39348761 |
| 99 | ribosome assembly (GO:0042255) | 3.38271573 |
| 100 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.36477289 |
| 101 | mitochondrion distribution (GO:0048311) | 3.36028115 |
| 102 | cellular protein complex localization (GO:0034629) | 3.35208781 |
| 103 | L-serine metabolic process (GO:0006563) | 3.34412837 |
| 104 | regulation of gastrulation (GO:0010470) | 3.33532920 |
| 105 | cardiovascular system development (GO:0072358) | 3.32435918 |
| 106 | morphogenesis of an epithelial fold (GO:0060571) | 3.30843085 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 3.30093758 |
| 108 | positive regulation of protein deacetylation (GO:0090312) | 3.28212706 |
| 109 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.27676691 |
| 110 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.27576943 |
| 111 | mRNA stabilization (GO:0048255) | 3.26608306 |
| 112 | RNA stabilization (GO:0043489) | 3.26608306 |
| 113 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.21669470 |
| 114 | metaphase plate congression (GO:0051310) | 3.21526427 |
| 115 | termination of RNA polymerase III transcription (GO:0006386) | 3.17064071 |
| 116 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.17064071 |
| 117 | * negative regulation of epidermis development (GO:0045683) | 3.16858307 |
| 118 | mitotic chromosome condensation (GO:0007076) | 3.16401864 |
| 119 | nucleoside transport (GO:0015858) | 3.16069936 |
| 120 | retinoic acid receptor signaling pathway (GO:0048384) | 3.15742184 |
| 121 | DNA replication initiation (GO:0006270) | 3.15249276 |
| 122 | ventricular cardiac muscle cell development (GO:0055015) | 3.14772052 |
| 123 | trophectodermal cell differentiation (GO:0001829) | 3.14499264 |
| 124 | regulation of helicase activity (GO:0051095) | 3.14046299 |
| 125 | DNA unwinding involved in DNA replication (GO:0006268) | 3.13501570 |
| 126 | mitochondrial DNA replication (GO:0006264) | 3.12286949 |
| 127 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.11255568 |
| 128 | mitochondrial RNA metabolic process (GO:0000959) | 3.10873636 |
| 129 | blastocyst development (GO:0001824) | 3.10597468 |
| 130 | kinetochore organization (GO:0051383) | 3.10518402 |
| 131 | negative regulation of gene silencing (GO:0060969) | 3.09965031 |
| 132 | establishment of viral latency (GO:0019043) | 3.09526281 |
| 133 | ribosomal small subunit biogenesis (GO:0042274) | 3.09192408 |
| 134 | kinetochore assembly (GO:0051382) | 3.08629674 |
| 135 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.08554306 |
| 136 | apoptotic DNA fragmentation (GO:0006309) | 3.07522728 |
| 137 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.06689329 |
| 138 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.06645298 |
| 139 | regulation of DNA-dependent DNA replication (GO:0090329) | 3.06095545 |
| 140 | regulation of double-strand break repair (GO:2000779) | 3.06038421 |
| 141 | DNA double-strand break processing (GO:0000729) | 3.04145312 |
| 142 | maternal placenta development (GO:0001893) | 3.04110903 |
| 143 | vitamin A metabolic process (GO:0006776) | 3.03976403 |
| 144 | activin receptor signaling pathway (GO:0032924) | 3.01963067 |
| 145 | SMAD protein signal transduction (GO:0060395) | 3.01582338 |
| 146 | nucleobase biosynthetic process (GO:0046112) | 3.01384281 |
| 147 | bone trabecula formation (GO:0060346) | 3.00203286 |
| 148 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.99997944 |
| 149 | microtubule severing (GO:0051013) | 2.98213135 |
| 150 | purine nucleobase biosynthetic process (GO:0009113) | 2.98184659 |
| 151 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.97480085 |
| 152 | epoxygenase P450 pathway (GO:0019373) | 2.97194235 |
| 153 | protein polyglutamylation (GO:0018095) | 2.95844504 |
| 154 | negative regulation of cell fate commitment (GO:0010454) | 2.95515018 |
| 155 | * somite rostral/caudal axis specification (GO:0032525) | 2.93932692 |
| 156 | ribosomal small subunit assembly (GO:0000028) | 2.90744289 |
| 157 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.88017917 |
| 158 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.88017917 |
| 159 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.88017917 |
| 160 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.88017917 |
| 161 | negative regulation of sister chromatid segregation (GO:0033046) | 2.88017917 |
| 162 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.87916452 |
| 163 | negative regulation of chromosome segregation (GO:0051985) | 2.86763046 |
| 164 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.85802520 |
| 165 | IMP metabolic process (GO:0046040) | 2.84118493 |
| 166 | serine family amino acid biosynthetic process (GO:0009070) | 2.82881631 |
| 167 | protein neddylation (GO:0045116) | 2.82689026 |
| 168 | DNA strand elongation (GO:0022616) | 2.82480034 |
| 169 | spliceosomal snRNP assembly (GO:0000387) | 2.80735193 |
| 170 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.79989399 |
| 171 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.79611288 |
| 172 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.79611288 |
| 173 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.79611288 |
| 174 | oxidative phosphorylation (GO:0006119) | 2.78741651 |
| 175 | DNA ligation (GO:0006266) | 2.78163481 |
| 176 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.77340173 |
| 177 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.75704314 |
| 178 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.75353424 |
| 179 | mitotic spindle checkpoint (GO:0071174) | 2.73993934 |
| 180 | positive regulation of ligase activity (GO:0051351) | 2.73590184 |
| 181 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.73056400 |
| 182 | daunorubicin metabolic process (GO:0044597) | 10.9031128 |
| 183 | polyketide metabolic process (GO:0030638) | 10.9031128 |
| 184 | doxorubicin metabolic process (GO:0044598) | 10.9031128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.14323482 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.14323482 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.14323482 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.67992629 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.56453515 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.21546877 |
| 7 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.17158201 |
| 8 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.98800364 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.97577587 |
| 10 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.88773087 |
| 11 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.80762377 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.71009255 |
| 13 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.66959586 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.46166571 |
| 15 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.43848849 |
| 16 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.42968705 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.42942221 |
| 18 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.38973766 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.36598413 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.16961673 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.13515362 |
| 22 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.13037209 |
| 23 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.98366729 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97887973 |
| 25 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97447110 |
| 26 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.96120884 |
| 27 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93693632 |
| 28 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.93467451 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.91865390 |
| 30 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.87211394 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.85554709 |
| 32 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.83731854 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82891768 |
| 34 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.81327374 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80743306 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.80177194 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79837112 |
| 38 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78192187 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75785954 |
| 40 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.70584641 |
| 41 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.67982682 |
| 42 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.64330897 |
| 43 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64027224 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.58894549 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58792938 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57184589 |
| 47 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.55506818 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54506486 |
| 49 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.53570202 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49960909 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47821252 |
| 52 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47326134 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.46930064 |
| 54 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.46852023 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.45452080 |
| 56 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.44542066 |
| 57 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.42881517 |
| 58 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.40913570 |
| 59 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.39591308 |
| 60 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38699358 |
| 61 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34734747 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.33724035 |
| 63 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.33651985 |
| 64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.32286921 |
| 65 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.28688125 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26910147 |
| 67 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.26720481 |
| 68 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.26171833 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25375439 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.24041908 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22844419 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21952706 |
| 73 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.18012351 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17032910 |
| 75 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.16272069 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16063116 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15377433 |
| 78 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13801902 |
| 79 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.13400973 |
| 80 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.11674568 |
| 81 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.11335273 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10120537 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07484205 |
| 84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.07065455 |
| 85 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.06135527 |
| 86 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05957404 |
| 87 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05672903 |
| 88 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.05403841 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05213483 |
| 90 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04486675 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04374004 |
| 92 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01096664 |
| 93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00057568 |
| 94 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.98056917 |
| 95 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.96933913 |
| 96 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96829638 |
| 97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95301386 |
| 98 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94722983 |
| 99 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93875184 |
| 100 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.93372828 |
| 101 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93277489 |
| 102 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92070407 |
| 103 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91869513 |
| 104 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90932999 |
| 105 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.87904930 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86193507 |
| 107 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.86026807 |
| 108 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.83547850 |
| 109 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.82652843 |
| 110 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.81223833 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79915238 |
| 112 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.79532423 |
| 113 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.79288336 |
| 114 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.79233936 |
| 115 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.77676567 |
| 116 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77143699 |
| 117 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.76054304 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75124175 |
| 119 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.74915402 |
| 120 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.73309339 |
| 121 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.72660349 |
| 122 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.72149395 |
| 123 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.72004523 |
| 124 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.69727272 |
| 125 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.69650344 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.69103503 |
| 127 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.68504773 |
| 128 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.68462660 |
| 129 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.66780477 |
| 130 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.65548808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.55948470 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.54540378 |
| 3 | MP0002254_reproductive_system_inflammat | 4.43410227 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.27712771 |
| 5 | MP0008057_abnormal_DNA_replication | 3.78746407 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.37316164 |
| 7 | MP0005075_abnormal_melanosome_morpholog | 3.34261664 |
| 8 | MP0005499_abnormal_olfactory_system | 3.15814484 |
| 9 | MP0005394_taste/olfaction_phenotype | 3.15814484 |
| 10 | MP0003941_abnormal_skin_development | 3.07694763 |
| 11 | MP0003718_maternal_effect | 3.01432664 |
| 12 | MP0004858_abnormal_nervous_system | 2.91272786 |
| 13 | MP0002332_abnormal_exercise_endurance | 2.70433683 |
| 14 | MP0003122_maternal_imprinting | 2.66795495 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.43734052 |
| 16 | MP0006035_abnormal_mitochondrial_morpho | 2.39939554 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.34898558 |
| 18 | MP0003121_genomic_imprinting | 2.34256350 |
| 19 | MP0008004_abnormal_stomach_pH | 2.28986581 |
| 20 | MP0002653_abnormal_ependyma_morphology | 2.27724892 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.12436605 |
| 22 | MP0003567_abnormal_fetal_cardiomyocyte | 2.01608691 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.99428248 |
| 24 | MP0000537_abnormal_urethra_morphology | 1.94111136 |
| 25 | MP0003077_abnormal_cell_cycle | 1.93992312 |
| 26 | * MP0005380_embryogenesis_phenotype | 1.86440360 |
| 27 | * MP0001672_abnormal_embryogenesis/_devel | 1.86440360 |
| 28 | MP0002088_abnormal_embryonic_growth/wei | 1.82273369 |
| 29 | MP0003938_abnormal_ear_development | 1.81082571 |
| 30 | MP0003984_embryonic_growth_retardation | 1.81059422 |
| 31 | MP0003111_abnormal_nucleus_morphology | 1.76482832 |
| 32 | MP0003123_paternal_imprinting | 1.76319582 |
| 33 | MP0002277_abnormal_respiratory_mucosa | 1.75196010 |
| 34 | MP0001293_anophthalmia | 1.74160712 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.70840410 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.66091851 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.62651266 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 1.60074915 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.54023458 |
| 40 | MP0001849_ear_inflammation | 1.53043949 |
| 41 | MP0001529_abnormal_vocalization | 1.51660830 |
| 42 | MP0002736_abnormal_nociception_after | 1.51626064 |
| 43 | MP0004133_heterotaxia | 1.50993870 |
| 44 | MP0001188_hyperpigmentation | 1.47238264 |
| 45 | MP0005266_abnormal_metabolism | 1.46813320 |
| 46 | MP0006054_spinal_hemorrhage | 1.45966855 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.42218332 |
| 48 | MP0009672_abnormal_birth_weight | 1.40132437 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.39633055 |
| 50 | MP0009697_abnormal_copulation | 1.38813665 |
| 51 | MP0006082_CNS_inflammation | 1.38398287 |
| 52 | MP0002092_abnormal_eye_morphology | 1.37982492 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.36817510 |
| 54 | * MP0002086_abnormal_extraembryonic_tissu | 1.33928646 |
| 55 | * MP0002085_abnormal_embryonic_tissue | 1.33724790 |
| 56 | MP0002932_abnormal_joint_morphology | 1.32274596 |
| 57 | MP0003195_calcinosis | 1.31652184 |
| 58 | MP0000049_abnormal_middle_ear | 1.31356359 |
| 59 | MP0000762_abnormal_tongue_morphology | 1.28949383 |
| 60 | MP0008789_abnormal_olfactory_epithelium | 1.28584366 |
| 61 | MP0008932_abnormal_embryonic_tissue | 1.21939812 |
| 62 | MP0000490_abnormal_crypts_of | 1.18924509 |
| 63 | MP0009840_abnormal_foam_cell | 1.18671931 |
| 64 | MP0004272_abnormal_basement_membrane | 1.17148480 |
| 65 | MP0003283_abnormal_digestive_organ | 1.15671137 |
| 66 | MP0001730_embryonic_growth_arrest | 1.15670324 |
| 67 | MP0001348_abnormal_lacrimal_gland | 1.13697932 |
| 68 | MP0003119_abnormal_digestive_system | 1.12974708 |
| 69 | MP0003315_abnormal_perineum_morphology | 1.11525094 |
| 70 | MP0002233_abnormal_nose_morphology | 1.10960369 |
| 71 | MP0004197_abnormal_fetal_growth/weight/ | 1.10742748 |
| 72 | * MP0002084_abnormal_developmental_patter | 1.10544634 |
| 73 | MP0000313_abnormal_cell_death | 1.10375935 |
| 74 | MP0008007_abnormal_cellular_replicative | 1.10111366 |
| 75 | MP0008872_abnormal_physiological_respon | 1.08411881 |
| 76 | * MP0003890_abnormal_embryonic-extraembry | 1.07727517 |
| 77 | MP0002114_abnormal_axial_skeleton | 1.07260057 |
| 78 | MP0002697_abnormal_eye_size | 1.04506453 |
| 79 | MP0001697_abnormal_embryo_size | 1.04253290 |
| 80 | MP0002796_impaired_skin_barrier | 1.03853987 |
| 81 | MP0004043_abnormal_pH_regulation | 1.03027840 |
| 82 | MP0000462_abnormal_digestive_system | 1.02574605 |
| 83 | MP0000432_abnormal_head_morphology | 1.01184200 |
| 84 | MP0003385_abnormal_body_wall | 1.00876337 |
| 85 | MP0008995_early_reproductive_senescence | 0.99349168 |
| 86 | MP0000428_abnormal_craniofacial_morphol | 0.96464264 |
| 87 | MP0002132_abnormal_respiratory_system | 0.95527960 |
| 88 | * MP0002080_prenatal_lethality | 0.94714666 |
| 89 | MP0004381_abnormal_hair_follicle | 0.91333529 |
| 90 | MP0003935_abnormal_craniofacial_develop | 0.91074518 |
| 91 | MP0003787_abnormal_imprinting | 0.91066577 |
| 92 | MP0003755_abnormal_palate_morphology | 0.90766245 |
| 93 | MP0002938_white_spotting | 0.90345276 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.90306093 |
| 95 | MP0001984_abnormal_olfaction | 0.89939023 |
| 96 | MP0008058_abnormal_DNA_repair | 0.89438241 |
| 97 | MP0000470_abnormal_stomach_morphology | 0.87588877 |
| 98 | MP0005391_vision/eye_phenotype | 0.86762532 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.86400579 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 0.84387100 |
| 101 | MP0003786_premature_aging | 0.83668317 |
| 102 | MP0005395_other_phenotype | 0.83060774 |
| 103 | MP0001177_atelectasis | 0.82758235 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.82216792 |
| 105 | MP0002090_abnormal_vision | 0.81604732 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.80946997 |
| 107 | MP0008260_abnormal_autophagy | 0.80484738 |
| 108 | MP0002751_abnormal_autonomic_nervous | 0.79322018 |
| 109 | MP0000358_abnormal_cell_content/ | 0.78693995 |
| 110 | MP0002925_abnormal_cardiovascular_devel | 0.78691998 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.77574855 |
| 112 | MP0002249_abnormal_larynx_morphology | 0.75617452 |
| 113 | MP0005023_abnormal_wound_healing | 0.74868300 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.74714380 |
| 115 | MP0002269_muscular_atrophy | 0.73421741 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.72917817 |
| 117 | MP0001286_abnormal_eye_development | 0.72512528 |
| 118 | MP0005508_abnormal_skeleton_morphology | 0.72379159 |
| 119 | MP0005379_endocrine/exocrine_gland_phen | 0.72245818 |
| 120 | MP0002102_abnormal_ear_morphology | 0.72228739 |
| 121 | MP0002210_abnormal_sex_determination | 0.71670586 |
| 122 | MP0009703_decreased_birth_body | 0.71381976 |
| 123 | MP0000653_abnormal_sex_gland | 0.69260781 |
| 124 | MP0001145_abnormal_male_reproductive | 0.67641904 |
| 125 | MP0003136_yellow_coat_color | 0.67540609 |
| 126 | MP0005187_abnormal_penis_morphology | 0.67436161 |
| 127 | MP0002116_abnormal_craniofacial_bone | 0.67271557 |
| 128 | MP0002019_abnormal_tumor_incidence | 0.66992374 |
| 129 | MP0003861_abnormal_nervous_system | 0.66975097 |
| 130 | MP0003186_abnormal_redox_activity | 0.66792847 |
| 131 | * MP0002970_abnormal_white_adipose | 0.65722104 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.65279228 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.65231969 |
| 134 | MP0005384_cellular_phenotype | 0.64316786 |
| 135 | * MP0008770_decreased_survivor_rate | 0.63853068 |
| 136 | MP0002163_abnormal_gland_morphology | 0.63696582 |
| 137 | MP0001915_intracranial_hemorrhage | 0.63385287 |
| 138 | MP0001119_abnormal_female_reproductive | 0.61646338 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.60508615 |
| 140 | MP0003937_abnormal_limbs/digits/tail_de | 0.60469566 |
| 141 | MP0002111_abnormal_tail_morphology | 0.59109213 |
| 142 | MP0000749_muscle_degeneration | 0.58485709 |
| 143 | MP0003448_altered_tumor_morphology | 0.56253545 |
| 144 | MP0002081_perinatal_lethality | 0.55774478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 6.35737075 |
| 2 | Abdominal situs inversus (HP:0003363) | 5.55706973 |
| 3 | Abnormality of abdominal situs (HP:0011620) | 5.55706973 |
| 4 | Multiple enchondromatosis (HP:0005701) | 5.41172783 |
| 5 | Hepatoblastoma (HP:0002884) | 5.34001558 |
| 6 | Ependymoma (HP:0002888) | 4.88251848 |
| 7 | Rib fusion (HP:0000902) | 4.85222115 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 4.83659442 |
| 9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.17010153 |
| 10 | Neoplasm of striated muscle (HP:0009728) | 4.03396892 |
| 11 | * Bilateral microphthalmos (HP:0007633) | 3.97996503 |
| 12 | Rhabdomyosarcoma (HP:0002859) | 3.97432075 |
| 13 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.92439597 |
| 14 | Abnormal ventriculo-arterial connection (HP:0011563) | 3.68146430 |
| 15 | Transposition of the great arteries (HP:0001669) | 3.68146430 |
| 16 | Abnormal connection of the cardiac segments (HP:0011545) | 3.68146430 |
| 17 | Abnormality of the labia minora (HP:0012880) | 3.66270542 |
| 18 | Embryonal renal neoplasm (HP:0011794) | 3.63261260 |
| 19 | Chromsome breakage (HP:0040012) | 3.62893719 |
| 20 | Testicular atrophy (HP:0000029) | 3.59110056 |
| 21 | Rectovaginal fistula (HP:0000143) | 3.57588406 |
| 22 | Rectal fistula (HP:0100590) | 3.57588406 |
| 23 | Hyperglycinemia (HP:0002154) | 3.55634405 |
| 24 | Astrocytoma (HP:0009592) | 3.41865326 |
| 25 | Abnormality of the astrocytes (HP:0100707) | 3.41865326 |
| 26 | Abnormality of the salivary glands (HP:0010286) | 3.30589291 |
| 27 | Partial duplication of thumb phalanx (HP:0009944) | 3.29733277 |
| 28 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.19791854 |
| 29 | Intestinal fistula (HP:0100819) | 3.17360549 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 3.16530464 |
| 31 | Short humerus (HP:0005792) | 3.09312378 |
| 32 | Trismus (HP:0000211) | 3.09292181 |
| 33 | Vaginal fistula (HP:0004320) | 3.08503092 |
| 34 | Abnormal lung lobation (HP:0002101) | 3.06850223 |
| 35 | Carpal bone hypoplasia (HP:0001498) | 3.03713766 |
| 36 | Amyotrophic lateral sclerosis (HP:0007354) | 3.00449644 |
| 37 | Hyperglycinuria (HP:0003108) | 2.99940852 |
| 38 | Septo-optic dysplasia (HP:0100842) | 2.96934048 |
| 39 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.95317928 |
| 40 | Reduced antithrombin III activity (HP:0001976) | 2.95081272 |
| 41 | Absent radius (HP:0003974) | 2.94096495 |
| 42 | Horizontal nystagmus (HP:0000666) | 2.93855429 |
| 43 | Bifid tongue (HP:0010297) | 2.89940635 |
| 44 | Supernumerary spleens (HP:0009799) | 2.87471467 |
| 45 | Colon cancer (HP:0003003) | 2.86895288 |
| 46 | Birth length less than 3rd percentile (HP:0003561) | 2.86339013 |
| 47 | Partial duplication of the phalanx of hand (HP:0009999) | 2.86097157 |
| 48 | Acute encephalopathy (HP:0006846) | 2.85815118 |
| 49 | Acute necrotizing encephalopathy (HP:0006965) | 2.85294502 |
| 50 | Meckel diverticulum (HP:0002245) | 2.82903627 |
| 51 | Methylmalonic aciduria (HP:0012120) | 2.79788932 |
| 52 | Abnormal cartilage morphology (HP:0002763) | 2.79479474 |
| 53 | Anomalous pulmonary venous return (HP:0010772) | 2.77935110 |
| 54 | Hypochromic anemia (HP:0001931) | 2.76937382 |
| 55 | Aplasia involving forearm bones (HP:0009822) | 2.74122332 |
| 56 | Absent forearm bone (HP:0003953) | 2.74122332 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.68820589 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.68820589 |
| 59 | Preauricular skin tag (HP:0000384) | 2.67848322 |
| 60 | Abnormality of the ileum (HP:0001549) | 2.66685547 |
| 61 | Impulsivity (HP:0100710) | 2.66524686 |
| 62 | Shawl scrotum (HP:0000049) | 2.65962389 |
| 63 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.65842681 |
| 64 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.65842527 |
| 65 | Single umbilical artery (HP:0001195) | 2.65842527 |
| 66 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.65842527 |
| 67 | Glioma (HP:0009733) | 2.58815514 |
| 68 | Reticulocytopenia (HP:0001896) | 2.57453072 |
| 69 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.56918490 |
| 70 | Progressive muscle weakness (HP:0003323) | 2.55796931 |
| 71 | Horseshoe kidney (HP:0000085) | 2.47150274 |
| 72 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.45475194 |
| 73 | Large earlobe (HP:0009748) | 2.43366632 |
| 74 | Tongue fasciculations (HP:0001308) | 2.39757576 |
| 75 | Pendular nystagmus (HP:0012043) | 2.39559982 |
| 76 | Methylmalonic acidemia (HP:0002912) | 2.38682752 |
| 77 | Periauricular skin pits (HP:0100277) | 2.38532805 |
| 78 | Preauricular pit (HP:0004467) | 2.38532805 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 2.38221306 |
| 80 | Nasolacrimal duct obstruction (HP:0000579) | 2.38186094 |
| 81 | Medulloblastoma (HP:0002885) | 2.36900070 |
| 82 | Skin tags (HP:0010609) | 2.35748200 |
| 83 | Increased CSF lactate (HP:0002490) | 2.34811423 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34693008 |
| 85 | Abnormality of the pulmonary veins (HP:0011718) | 2.34443693 |
| 86 | Microvesicular hepatic steatosis (HP:0001414) | 2.31943233 |
| 87 | Abnormality of chromosome segregation (HP:0002916) | 2.28086521 |
| 88 | Generalized hypotonia (HP:0001290) | 2.27702866 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.26109897 |
| 90 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.25441256 |
| 91 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.25302298 |
| 92 | Tetraplegia (HP:0002445) | 2.23394827 |
| 93 | Type I transferrin isoform profile (HP:0003642) | 2.23163939 |
| 94 | Glossoptosis (HP:0000162) | 2.22702824 |
| 95 | Duodenal stenosis (HP:0100867) | 2.21758317 |
| 96 | Small intestinal stenosis (HP:0012848) | 2.21758317 |
| 97 | Microretrognathia (HP:0000308) | 2.19435366 |
| 98 | * Fused cervical vertebrae (HP:0002949) | 2.18791417 |
| 99 | Sensory axonal neuropathy (HP:0003390) | 2.17852465 |
| 100 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.16217556 |
| 101 | Short 5th finger (HP:0009237) | 2.16033532 |
| 102 | Progressive macrocephaly (HP:0004481) | 2.14999161 |
| 103 | Abnormality of the musculature of the hand (HP:0001421) | 2.14874201 |
| 104 | Muscle fibrillation (HP:0010546) | 2.14389486 |
| 105 | Mitochondrial inheritance (HP:0001427) | 2.13933737 |
| 106 | Stenosis of the external auditory canal (HP:0000402) | 2.13158114 |
| 107 | 3-Methylglutaconic aciduria (HP:0003535) | 2.12437798 |
| 108 | Anal stenosis (HP:0002025) | 2.10988185 |
| 109 | Premature ovarian failure (HP:0008209) | 2.10853021 |
| 110 | Homocystinuria (HP:0002156) | 2.10553347 |
| 111 | Abnormality of homocysteine metabolism (HP:0010919) | 2.10553347 |
| 112 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09483095 |
| 113 | Villous atrophy (HP:0011473) | 2.09483095 |
| 114 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.09166332 |
| 115 | Hyperventilation (HP:0002883) | 2.07445061 |
| 116 | Abnormality of the preputium (HP:0100587) | 2.05595116 |
| 117 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.04658430 |
| 118 | Increased connective tissue (HP:0009025) | 2.04033194 |
| 119 | Aplastic anemia (HP:0001915) | 2.03925476 |
| 120 | Progressive external ophthalmoplegia (HP:0000590) | 2.03881711 |
| 121 | Abnormality of the septum pellucidum (HP:0007375) | 2.03565331 |
| 122 | Hypoglycemic seizures (HP:0002173) | 2.03498314 |
| 123 | Neoplasm of the heart (HP:0100544) | 2.01589457 |
| 124 | Duplication of thumb phalanx (HP:0009942) | 2.00928123 |
| 125 | Asplenia (HP:0001746) | 2.00207662 |
| 126 | Abnormality of the pubic bones (HP:0003172) | 2.00076095 |
| 127 | Increased hepatocellular lipid droplets (HP:0006565) | 1.99572359 |
| 128 | Supernumerary nipples (HP:0002558) | 1.99323772 |
| 129 | Hypopigmentation of the fundus (HP:0007894) | 1.98422690 |
| 130 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97685181 |
| 131 | Pseudobulbar signs (HP:0002200) | 1.97392377 |
| 132 | Atresia of the external auditory canal (HP:0000413) | 1.97168809 |
| 133 | Facial cleft (HP:0002006) | 1.96877990 |
| 134 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.96719666 |
| 135 | Embryonal neoplasm (HP:0002898) | 1.96482240 |
| 136 | Upper limb muscle weakness (HP:0003484) | 1.96382919 |
| 137 | Absent septum pellucidum (HP:0001331) | 1.96051185 |
| 138 | Cerebral edema (HP:0002181) | 1.96024065 |
| 139 | Neoplasm of the oral cavity (HP:0100649) | 1.95948130 |
| 140 | Renal duplication (HP:0000075) | 1.95720559 |
| 141 | Choanal stenosis (HP:0000452) | 1.95399595 |
| 142 | Megaloblastic anemia (HP:0001889) | 1.95058818 |
| 143 | Difficulty running (HP:0009046) | 1.94842464 |
| 144 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.94282371 |
| 145 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.94200571 |
| 146 | Short hallux (HP:0010109) | 1.94046427 |
| 147 | Neoplasm of the adrenal gland (HP:0100631) | 1.93932473 |
| 148 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93678122 |
| 149 | Abnormality of chromosome stability (HP:0003220) | 1.93358316 |
| 150 | Missing ribs (HP:0000921) | 1.93253905 |
| 151 | Angiofibromas (HP:0010615) | 1.92518084 |
| 152 | Adenoma sebaceum (HP:0009720) | 1.92518084 |
| 153 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.89909683 |
| 154 | Abnormality of the umbilical cord (HP:0010881) | 1.89322893 |
| 155 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.89048413 |
| 156 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.87845943 |
| 157 | Hepatocellular necrosis (HP:0001404) | 1.87657452 |
| 158 | Increased serum lactate (HP:0002151) | 1.84350251 |
| 159 | Abnormal number of erythroid precursors (HP:0012131) | 1.83125557 |
| 160 | Clubbing of toes (HP:0100760) | 1.82223061 |
| 161 | Cerebral hypomyelination (HP:0006808) | 1.79790116 |
| 162 | Cerebral palsy (HP:0100021) | 1.79735751 |
| 163 | Abnormality of methionine metabolism (HP:0010901) | 1.78877177 |
| 164 | Abnormal protein glycosylation (HP:0012346) | 1.77425682 |
| 165 | Abnormal glycosylation (HP:0012345) | 1.77425682 |
| 166 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.77425682 |
| 167 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.77425682 |
| 168 | Agnosia (HP:0010524) | 1.76338222 |
| 169 | Hypoplastic pelvis (HP:0008839) | 1.76181665 |
| 170 | Absent eyebrow (HP:0002223) | 1.75989706 |
| 171 | Hypoalphalipoproteinemia (HP:0003233) | 1.75547245 |
| 172 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.74765107 |
| 173 | Leukodystrophy (HP:0002415) | 1.72923113 |
| 174 | Abnormality of the clitoris (HP:0000056) | 1.72909712 |
| 175 | Choanal atresia (HP:0000453) | 1.72752078 |
| 176 | Abnormality of vitamin B metabolism (HP:0004340) | 1.71452503 |
| 177 | Increased serum pyruvate (HP:0003542) | 1.71250451 |
| 178 | Renal agenesis (HP:0000104) | 1.70788960 |
| 179 | Lactic acidosis (HP:0003128) | 1.68570426 |
| 180 | Biliary tract neoplasm (HP:0100574) | 1.67092861 |
| 181 | Lipid accumulation in hepatocytes (HP:0006561) | 1.66915936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.51179574 |
| 2 | PBK | 7.24154618 |
| 3 | GRK5 | 5.13683830 |
| 4 | ERN1 | 4.32697619 |
| 5 | GRK6 | 4.07797552 |
| 6 | ADRBK2 | 3.08818909 |
| 7 | GRK1 | 3.08070083 |
| 8 | VRK2 | 3.06906712 |
| 9 | PLK4 | 2.93011209 |
| 10 | TTK | 2.90343558 |
| 11 | CSF1R | 2.86529553 |
| 12 | MST4 | 2.83047513 |
| 13 | MKNK2 | 2.64588286 |
| 14 | TGFBR2 | 2.64506980 |
| 15 | TYRO3 | 2.51751813 |
| 16 | GRK7 | 2.45010031 |
| 17 | STK16 | 2.42210922 |
| 18 | ZAK | 2.40282546 |
| 19 | MATK | 2.40150901 |
| 20 | MAPK7 | 2.32769194 |
| 21 | TSSK6 | 2.27542516 |
| 22 | LMTK2 | 2.25575325 |
| 23 | PLK3 | 2.23232511 |
| 24 | STK10 | 2.23224074 |
| 25 | EIF2AK3 | 2.11542911 |
| 26 | MKNK1 | 2.04765027 |
| 27 | MOS | 2.03640681 |
| 28 | CDK19 | 1.92909579 |
| 29 | EIF2AK1 | 1.91464794 |
| 30 | CDK7 | 1.86975460 |
| 31 | WNK1 | 1.81199920 |
| 32 | PDK2 | 1.79668401 |
| 33 | EPHA2 | 1.74807885 |
| 34 | TRIM28 | 1.69767724 |
| 35 | TNIK | 1.54136509 |
| 36 | NME1 | 1.46752783 |
| 37 | PRKG2 | 1.42917273 |
| 38 | CAMK4 | 1.42160540 |
| 39 | TAF1 | 1.41092095 |
| 40 | CHEK2 | 1.40936238 |
| 41 | PAK4 | 1.40569636 |
| 42 | WNK3 | 1.39613647 |
| 43 | OXSR1 | 1.36760415 |
| 44 | AKT3 | 1.35705482 |
| 45 | PLK1 | 1.35627253 |
| 46 | NUAK1 | 1.35437171 |
| 47 | NTRK1 | 1.32803689 |
| 48 | SMG1 | 1.28130843 |
| 49 | WEE1 | 1.23238221 |
| 50 | BRSK2 | 1.22151276 |
| 51 | TIE1 | 1.14397341 |
| 52 | MARK2 | 1.10976170 |
| 53 | HIPK2 | 1.05666137 |
| 54 | PHKG2 | 1.03830627 |
| 55 | PHKG1 | 1.03830627 |
| 56 | BUB1 | 1.02460064 |
| 57 | ADRBK1 | 1.01026529 |
| 58 | CDC7 | 1.00120620 |
| 59 | MAP2K4 | 0.95927895 |
| 60 | BMPR1B | 0.94505942 |
| 61 | PLK2 | 0.92978613 |
| 62 | MAP3K10 | 0.91466082 |
| 63 | FGFR3 | 0.89309678 |
| 64 | CHEK1 | 0.89192569 |
| 65 | BRSK1 | 0.86944672 |
| 66 | EIF2AK2 | 0.86006689 |
| 67 | ALK | 0.85726341 |
| 68 | RPS6KB2 | 0.81750068 |
| 69 | AKT2 | 0.77082910 |
| 70 | ERBB4 | 0.76818942 |
| 71 | NEK2 | 0.76046948 |
| 72 | FGFR1 | 0.75233486 |
| 73 | MAP2K6 | 0.74330399 |
| 74 | MAP3K12 | 0.70222322 |
| 75 | CSK | 0.69058123 |
| 76 | KDR | 0.66319065 |
| 77 | AURKA | 0.61084882 |
| 78 | NEK1 | 0.57320449 |
| 79 | CDK2 | 0.56773420 |
| 80 | MAPK12 | 0.56304812 |
| 81 | BRAF | 0.55673468 |
| 82 | LATS2 | 0.54473555 |
| 83 | PRKCI | 0.53625488 |
| 84 | CSNK1G1 | 0.53146566 |
| 85 | SRPK1 | 0.52669829 |
| 86 | MTOR | 0.51859160 |
| 87 | AURKB | 0.51055497 |
| 88 | MAP3K7 | 0.50312664 |
| 89 | DYRK3 | 0.49740672 |
| 90 | CDK4 | 0.49520312 |
| 91 | ATM | 0.44950345 |
| 92 | CSNK2A1 | 0.44407314 |
| 93 | PASK | 0.43290681 |
| 94 | MAPKAPK3 | 0.42835627 |
| 95 | PAK1 | 0.39166460 |
| 96 | TESK2 | 0.36753037 |
| 97 | CSNK1E | 0.35847015 |
| 98 | MAP4K2 | 0.35320759 |
| 99 | IKBKB | 0.33285638 |
| 100 | DYRK2 | 0.32643213 |
| 101 | CSNK2A2 | 0.32540453 |
| 102 | CDK1 | 0.31522722 |
| 103 | IGF1R | 0.31032333 |
| 104 | MAP3K9 | 0.30937147 |
| 105 | PRKCD | 0.30880832 |
| 106 | DAPK1 | 0.30695997 |
| 107 | MELK | 0.30527052 |
| 108 | TGFBR1 | 0.29579149 |
| 109 | ATR | 0.28789604 |
| 110 | CSNK1G2 | 0.28281866 |
| 111 | TAOK2 | 0.28187900 |
| 112 | ERBB2 | 0.27410872 |
| 113 | MAPK10 | 0.27380237 |
| 114 | DMPK | 0.26556171 |
| 115 | PRKDC | 0.25861231 |
| 116 | STK3 | 0.25428533 |
| 117 | WNK4 | 0.24798623 |
| 118 | FGFR2 | 0.24436985 |
| 119 | CSNK1G3 | 0.23192290 |
| 120 | ILK | 0.22861517 |
| 121 | PRKCG | 0.22747825 |
| 122 | PTK2 | 0.22068503 |
| 123 | MAPK1 | 0.22008411 |
| 124 | PINK1 | 0.21563404 |
| 125 | CASK | 0.21366690 |
| 126 | GSK3B | 0.21322478 |
| 127 | DAPK3 | 0.21291639 |
| 128 | MAPK14 | 0.20652946 |
| 129 | CDK8 | 0.20286720 |
| 130 | STK39 | 0.19768216 |
| 131 | ITK | 0.19659170 |
| 132 | PRPF4B | 0.19382663 |
| 133 | NME2 | 0.18589716 |
| 134 | CSNK1A1 | 0.18523501 |
| 135 | NLK | 0.18105013 |
| 136 | INSR | 0.17944608 |
| 137 | MAP3K8 | 0.17879847 |
| 138 | INSRR | 0.17027420 |
| 139 | CDK15 | 0.15590916 |
| 140 | CDK11A | 0.15500332 |
| 141 | MAPK4 | 0.15183854 |
| 142 | BMX | 0.14039214 |
| 143 | STK4 | 0.13923247 |
| 144 | PDGFRA | 0.13896003 |
| 145 | STK38 | 0.13762218 |
| 146 | PRKACB | 0.12895795 |
| 147 | PRKACG | 0.12649843 |
| 148 | DYRK1A | 0.12629220 |
| 149 | ACVR1B | 0.11647730 |
| 150 | CDK18 | 0.11617703 |
| 151 | BRD4 | 0.11461803 |
| 152 | VRK1 | 0.11246135 |
| 153 | GSK3A | 0.11173703 |
| 154 | RIPK1 | 0.10857277 |
| 155 | ICK | 0.10420995 |
| 156 | PRKD2 | 0.10074527 |
| 157 | FLT3 | 0.09511085 |
| 158 | PIM1 | 0.08829462 |
| 159 | PRKAA1 | 0.07908097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.67878598 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.52437730 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.80897364 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.60301394 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.74481686 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.67108024 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.48653560 |
| 8 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.48344245 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.39588659 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.36653231 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.29747900 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.21741909 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.12971214 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.07080573 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03744035 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.02248475 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.96645999 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.92866815 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.92116449 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86154855 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85064707 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.82360027 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.80341239 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.79099781 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.77362517 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.70926927 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.62951740 |
| 28 | Spliceosome_Homo sapiens_hsa03040 | 1.62534302 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62263205 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59981546 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.58972149 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.55930109 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54463682 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50713487 |
| 35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48416578 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.47527127 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.41903436 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.39002998 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30884148 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24588922 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19350522 |
| 42 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.17143168 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16173055 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13181032 |
| 45 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.07872745 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06850051 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06154447 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03748733 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.99840314 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98966458 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98399092 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96290096 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94956669 |
| 54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94924106 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.94759046 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.90793806 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90674861 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89114903 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86760044 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85014929 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84662584 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83473967 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83127566 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83099526 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82598854 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78827059 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72636036 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.72537607 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71741289 |
| 70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70531312 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68634703 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68067305 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66802885 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66782771 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64443075 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64016871 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63994714 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63839238 |
| 79 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63547727 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63282576 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63034732 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62921203 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62254940 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62059084 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60479546 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59768256 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55905193 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54549480 |
| 89 | Peroxisome_Homo sapiens_hsa04146 | 0.54436300 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54158751 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53854050 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52909994 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52387157 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51983510 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51968583 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49921441 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47705522 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46826998 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44954373 |
| 100 | Proteasome_Homo sapiens_hsa03050 | 0.43634653 |
| 101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42571020 |
| 102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42106566 |
| 103 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41728321 |
| 104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41014637 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40106448 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40009982 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39987967 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.39630450 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38603005 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38121678 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37973454 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37440064 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37193258 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36526538 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36043156 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34984510 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.33718362 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32675791 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.31269594 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29145440 |
| 121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29115443 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28345057 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27923252 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26684425 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26544207 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26134912 |
| 127 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25300397 |
| 128 | Phototransduction_Homo sapiens_hsa04744 | 0.25251527 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24430505 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24395797 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23240563 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21642007 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21470071 |
| 134 | Purine metabolism_Homo sapiens_hsa00230 | 0.20894530 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18713131 |
| 136 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.17555253 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15269630 |
| 138 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14546137 |
| 139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14363133 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13900158 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.13733230 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13011153 |
| 143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12505601 |
| 144 | Colorectal cancer_Homo sapiens_hsa05210 | 0.12270302 |
| 145 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.11464986 |

